178 related articles for article (PubMed ID: 32490648)
1. The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma.
Gülsoy Kirnap N; Turhan Iyidir Ö; Bozkuş Y; Işildak ŞM; Anil C; Firat SN; Demir C; Nar A; Başçil Tütüncü N
Turk J Med Sci; 2020 Jun; 50(4):870-876. PubMed ID: 32490648
[TBL] [Abstract][Full Text] [Related]
2. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
[No Abstract] [Full Text] [Related]
3. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
Altuntaş SÇ; Hocaoğlu Ç
Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.
Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bax JJ; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Mar; 64(3):284-91. PubMed ID: 16487438
[TBL] [Abstract][Full Text] [Related]
5. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
[TBL] [Abstract][Full Text] [Related]
6. Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
Vigário Pdos S; Chachamovitz DS; Teixeira Pde F; Rocque Mde L; Santos ML; Vaisman M
Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):274-81. PubMed ID: 24863090
[TBL] [Abstract][Full Text] [Related]
7. Iatrogenic Subclinical Hyperthyroidism Does Not Promote Weight Loss.
Kedia R; Lowes A; Gillis S; Markert R; Koroscil T
South Med J; 2016 Feb; 109(2):97-100. PubMed ID: 26840964
[TBL] [Abstract][Full Text] [Related]
8. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[TBL] [Abstract][Full Text] [Related]
9. The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.
Moon JH; Ahn S; Seo J; Han JW; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Kim KW; Jang HC
J Clin Endocrinol Metab; 2014 Oct; 99(10):3782-9. PubMed ID: 25029415
[TBL] [Abstract][Full Text] [Related]
10. Assessment of anxiety in subclinical thyroid disorders.
Sait Gönen M; Kisakol G; Savas Cilli A; Dikbas O; Gungor K; Inal A; Kaya A
Endocr J; 2004 Jun; 51(3):311-5. PubMed ID: 15256776
[TBL] [Abstract][Full Text] [Related]
11. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
12. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.
Heemstra KA; Smit JW; Eustatia-Rutten CF; Heijboer AC; Frölich M; Romijn JA; Corssmit EP
Clin Endocrinol (Oxf); 2006 Dec; 65(6):737-44. PubMed ID: 17121524
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric symptoms and diagnoses in thyroid disorders: a cross-sectional study.
Aslan S; Ersoy R; Kuruoglu AC; Karakoc A; Cakir N
Int J Psychiatry Clin Pract; 2005; 9(3):187-92. PubMed ID: 24937789
[TBL] [Abstract][Full Text] [Related]
14. Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
Jin S; Yang YT; Bao W; Bai Y; Ai JW; Liu Y; Yong H
Endocrine; 2019 Aug; 65(2):327-337. PubMed ID: 31056722
[TBL] [Abstract][Full Text] [Related]
15. Differentiated thyroid cancer: effect on quality of life, depression, and anxiety.
Helvacı BC; Yalçın MM; Yalcın ŞNG; Arslan E; Altinova AE; Törüner FB
Hormones (Athens); 2023 Sep; 22(3):367-374. PubMed ID: 37084015
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract][Full Text] [Related]
17. Quality of life, muscle strength, and fatigue perception in patients on suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
de Oliveira Chachamovitz DS; dos Santos Vigário P; Nogueira Cordeiro MF; de Castro CL; Vaisman M; dos Santos Teixeira Pde F
Am J Clin Oncol; 2013 Aug; 36(4):354-61. PubMed ID: 22643561
[TBL] [Abstract][Full Text] [Related]
18. The problem of exogenous subclinical hyperthyroidism.
Batrinos ML
Hormones (Athens); 2006; 5(2):119-25. PubMed ID: 16807224
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life, Anxiety and Depression in Patients with Differentiated Thyroid Cancer under Short Term Hypothyroidism Induced by Levothyroxine Withdrawal.
Badihian S; Jalalpour P; Mirdamadi M; Moslehi M
Klin Onkol; 2016; 29(6):439-444. PubMed ID: 27951721
[TBL] [Abstract][Full Text] [Related]
20. [The role of coping strategies, depression and anxiety in thyroid disease].
Pápai A; Coșa LE; Cozma MM; Mihai A
Orv Hetil; 2021 Feb; 162(7):262-268. PubMed ID: 33582652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
